- Breaking News Software ensures translation accuracy
- Breaking News GM to honour all agreements
- Breaking News 5 Iranians nabbed with syabu-soaked clothes
- Breaking News Pei Tty-Eei Hui's chances look bleak
SurfControl helps companies strategically manage spam and e-mail threats through new online tool; ROI Calculator for Anti-Spam tools helps IT managers quantify and communicate the cost and benefits of e-mail filtering solutions.
0 Comments | M2 Presswire, March, 2004
M2 PRESSWIRE-22 March 2004-SurfControl: SurfControl helps companies strategically manage spam and e-mail threats through new online tool; ROI Calculator for Anti-Spam tools helps IT managers quantify and communicate the cost and benefits of e-mail filtering solutions(C)1994-2004 M2 COMMUNICATIONS LTD RDATE:03222004 Manchester, U.K.
- SurfControl (London:SRF), the world's number one Web and e-mail filtering company, today announced the availability of a free online resource to help corporate IT managers quantify the cost of spam and assess the business value of e-mail filtering solutions. According to a recent study of spam and anti-spam solutions by IDC, a leading global industry analyst firm, the majority of IT managers from the public and private sector...
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Industry Experts Launch Money Management Resources to Help People Overcome Debt and Learn Proper Money Management Practices
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Portfolio forecasting tools: what you need to know
- Banking technology, technological learning and competition: comparative case studies in Thai banking
- John Seely Brown Inducted Into 2004 Industry Hall of Fame
- SmartDisk's New VST Flash Media Reader(TM) Reads SmartMedia(TM), CompactFlash(TM) From A Single Desktop Unit
- FDA Approves REMICADE(R) for Ninth Indication: Psoriatic Arthritis